ASHP therapeutic position statement on strict glycemic control in patients with diabetes

American Journal of Health-System Pharmacy

Volumn 60, Issue 22, 2003, Pages 2357-2362

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

ARTICLE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCOSYLATION; HUMAN; HYPERGLYCEMIA; MEDICAL SOCIETY; PATHOPHYSIOLOGY; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; CLINICAL TRIAL; CONSENSUS; DISEASE MANAGEMENT; DRUG EFFECT; HEALTH CARE ORGANIZATION; METABOLISM;

BLOOD GLUCOSE; CLINICAL TRIALS; CONSENSUS; DIABETES MELLITUS; DISEASE MANAGEMENT; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; SOCIETIES, PHARMACEUTICAL;

EID: 1542750042     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.22.2357     Document Type: Article

References (27)

1. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003; 26 (suppl 1):S32-50.
2. American College of Endocrinology. Consensus Statement on Guidelines for Glycemic Control. Endocr Pract. 2002; 8 (Suppl 1):5-11.
3. Diabetes 2001 vital statistics. Alexandria, VA: American Diabetes Association; 2001.
4. Benjamin SM, Valdez R, Geiss LS et al. Estimated number of adults with prediabetes in the U.S. in 2000: opportunities for prevention. Diabetes Care. 2003; 26:645-9.
5. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988; 318:1315-21.
6. Libby P. Atherosclerosis: the new view. Sci Am. 2002; 286(May):46-55.
7. Frank RN. Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors. Am J Ophthalmol. 2002; 133:693-8.
8. Setter SM, Campbell RK, Cahoon CJ. The emerging role of protein kinase C β (PKC β) in diabetes complications. Adv Pharm. 2003; 1:149-58.
9. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329:977-86.
10. Ohkubo Y, Kishikawa H, Araki E et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin diabetes mellitus: a randomized, prospective 6-year study. Diabetes Res Clin Pract. 1995; 28:103-17.
11. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352:837-53.
12. Klein R, Klein BE, Moss SE et al. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med. 1994; 154:2169-78.
13. Reduce HbA1c by just 1% and see what happens. www.diabetesincontrol.com/ issue59/#itemif1 (accessed 2003 Jul 25).
14. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-97.
15. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998; 352:854-65.
16. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995; 18:258-68.
17. McPherson ML. ASHP Ambulatory Care Clinical Skills Program: type 2 diabetes mellitus management module. Bethesda, MD: American Society of Health-System Pharmacists; 2000:4.
18. Baran RW, Crumlish K, Patterson H et al. Improving outcomes of community-dwelling older patients with diabetes through pharmacist counseling. Am J Health-Syst Pharm. 1999; 56:1535-9.
19. Coast-Senior EA, Kroner BA, Kelley CL et al. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother. 1998; 32:636-41.
20. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346:393-403.
21. Medications for the treatment of diabetes. Alexandria, VA: American Diabetes Association; 2000.
22. American Diabetes Association. Preconception care of women with diabetes. Diabetes Care. 2003; 26(suppl 1):S91-3.
23. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2003; 26(suppl 1):S103-5.
24. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997; 157:545-52.
25. Hirsch IB, Brunzell J, Paauw DS. Inpatient management of adults with diabetes. Diabetes Care. 1995; 18:870-7.
26. American Diabetes Association. Self-monitoring of blood glucose. Diabetes Care. 1994; 17:81-6.
27. American Diabetes Association. Bedside blood glucose monitoring in hospitals. Diabetes Care. 2003; 26(suppl 1):S119.